Sign in

CIK 0001533040

  • Non-accelerated filer
  • Smaller reporting company

Phio Pharmaceuticals Corp.

Sign in to watch
Ticker
PHIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453215903
Phone
+1 508-767-3861
Business address
411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
Former names
RXi Pharmaceuticals Corp
Open-market buys, last 90 days
$86,928
in 8 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$86,928. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-13 Deming David H Director Purchase +3,000 $0.83 $3K 61,800
2026-11-12 Deming David H Director Purchase +9,000 $0.81 $7K 58,800
2026-11-11 Deming David H Director Purchase +5,200 $0.84 $4K 49,800
2026-11-10 Deming David H Director Purchase +6,800 $0.84 $6K 44,600

Page 1 of 1 · 4 trades